Skip to main
PHR

Phreesia Inc (PHR) Stock Forecast & Price Target

Phreesia Inc (PHR) Analyst Ratings

Based on 15 analyst ratings
Buy
Strong Buy 20%
Buy 40%
Hold 40%
Sell 0%
Strong Sell 0%

Bulls say

Phreesia is expected to continue its strong financial performance because of its integrated platform and its ability to address key challenges in healthcare delivery. Despite concerns about permission and consent for showing ads, the company has maintained high rates and has made changes to improve their authorization experience. While their top-line deceleration may impact their Rule of 40 objective, their position in the patient engagement market makes them well-positioned for growth. However, the recent slowdown and economic impacts may put their price target and rating at risk, and it is important to closely monitor financial metrics going forward.

Bears say

Phreesia is facing several headwinds that may impact its growth in the coming years, including a slowdown in subscription revenue, increasing competition in the healthcare industry, and the risk of losing clients due to evolving industry standards and technology. Additionally, the company's recent acquisition of AccessOne may prove to be challenging to integrate and may not generate expected revenue growth. These factors, along with the uncertainty around back-half Network Solutions commitments, have led to a disappointing updated revenue guidance for FY27. Despite the company's focus on improving the patient experience and operational efficiency, there are concerns about the sustainability of its pricing strategy, particularly in the face of pricing pressure from its pharmaceutical clients and the increasing shift towards telehealth services. The company's recent stock offering also raises questions about its ability to generate positive free cash flow in the near future. Overall, these risks and challenges contribute to a negative outlook on Phreesia's stock.

Phreesia Inc (PHR) has been analyzed by 15 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 40% recommend Buy, 40% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Phreesia Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Phreesia Inc (PHR) Forecast

Analysts have given Phreesia Inc (PHR) a Buy based on their latest research and market trends.

According to 15 analysts, Phreesia Inc (PHR) has a Buy consensus rating as of Aug 25, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $16.40, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $16.40, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Phreesia Inc (PHR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.